ICOS and angioimmunoblastic T-cell lymphoma: Taken together, the presence of RHOAG17V enhances both TCR and ICOS signaling possibly through independent mechanisms, specifies Tfh lineage, maintains Tfh phenotypes, and provokes autoimmune reactions, all reminiscent of outcomes associated with AITL and other Tfh lymphomas (Fig. 3).